Agitation – Talk Bio

Actionable Insights Powered by AI

Exciva Raises $59M Series B to Fund Phase 2 Trial of Deraphan for Alzheimer’s Agitation

3 days ago3 days ago talkbio0Tagged Agitation, Alzheimer 's, Deraphan, Exciva, methionine, Neuropsychiatry, Phase 2, Series B

Exciva; Series B; $59M; Alzheimer’s; agitation; Deraphan; Phase 2; neuropsychiatry

Otsuka Discontinues Alzheimer’s Agitation Drug Development Following Second Unsuccessful Trial

2 years ago talkbio0Tagged Agitation, Alzheimer 's disease, Clinical Trials, Discontinuation (procedure), Drug Development, Failed, Otsuka, trials

Otsuka, Alzheimer’s disease, agitation, drug development, clinical trials, failed trials, discontinuation